Biomedfactors Modify Pharmacology Actions
-
Upload
ferry-prawira -
Category
Documents
-
view
216 -
download
1
Transcript of Biomedfactors Modify Pharmacology Actions
![Page 1: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/1.jpg)
FACTORS MODIFY PHARMACOLOGY ACTIONS
DR DATTEN BANGUN, MSc,Sp.FKDept.Farmakologi & Therapeutik
Fak.Kedokteran BiomedisUSU,MEDAN
![Page 2: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/2.jpg)
Purpose of Drug Therapy
• “… to prevent, control or cure various disease states.”
• To achieve this, the right drug dose must be delivered to the tissues
• Every doctor must know…– speed of onset of drug action– intensity of drug effect– duration of drug action
![Page 3: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/3.jpg)
Key Points
• The most important properties of an ideal drug are: effectiveness, safety, and selectivity.
• If the drug is not effective, it should not be used.• There is no such drug as safe drug: all drugs can cause
harm.• There is no such thing as selective drug: all drugs can
cause side effects.• The objective of drug therapy is to provide maximum
benefit within minimum harm.• Because all patients are unique, drug therapy must be
tailored to each individual.
![Page 4: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/4.jpg)
General ConceptsDrug Dose
Administration
Drug Effect or Response
Pharmaceutical
Pharmacokinetics
Pharmacodynamics
Pharmacotherapeutics
Disintegrationof Drug
Absorption/distributionmetabolism/excretion
Drug/ReceptorInteraction
![Page 5: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/5.jpg)
Therapeutic Objective
To provide maximum benefit with minimum harm
Factors that determine Intensity of Response
* Administration- dosage size and route* Pharmacokinetic processes* Pharmacodynamics* Individual Variations
![Page 6: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/6.jpg)
Factors that determine the intensity of drug response
![Page 7: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/7.jpg)
FACTORS MODIFYING DRUG ACTION
I. Physiological Factors. II. Pathological Factors (Diseases). III. Genetic Factors. IV. Environmental Factors. V. Interaction with other drugs.
![Page 8: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/8.jpg)
FACTORS MODIFYING DRUG ACTIONS
Individuals vary in drug effect from time to time & from other individuals
Nature of systemic effects of drugs depends on following factors:Physiological factors (age, sex, pregnancy, lactation, body wt., food)Pathological state (kidney or liver disease)Environmental factors
cont.
![Page 9: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/9.jpg)
Psychological /emotional state
Interaction with other drugs (drug-drug interactions)
![Page 10: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/10.jpg)
I. Physiological factors
i) Age Extreme of age show extreme drug
sensitivity Newborn babies & elderly= greater & more
prolonged effect of drugs b/c of less efficient drug metabolism & renal functions
![Page 11: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/11.jpg)
InfantsPremature infants= poor renal & hepatic functions more
sensitive to various drugs
E.g., Chloramphenicol = Gray baby syndrome
(inadequate metabolism) Ampicillin & morphine = GIT absorption
(less acidity) Tetrycycline = staining of teeth Corticosteroids = retardation of growth in
children
![Page 12: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/12.jpg)
Elderly
• Renal & hepatic function decline slowly after middle age
• Activity of hepatic microsomal enzymes decline with age
• Vd of lipid soluble drugs increases• Elderly require less due to degenerative
changes in kidney, liver, brain, heartCont.,
![Page 13: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/13.jpg)
E.g., Diazepam & benzodiazepines = t1/2 Digoxin = Vd
Benzodiazepines= more confusion & less sedation in elderly
Hypotensive dugs= postural hypotension in elderly
![Page 14: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/14.jpg)
ii) Sex/Gender
• Response & dose= different in men & women• Metabolism of some drugs= less in women
(more adipose tissues)E.g., alcohol, diazepam • Women require lesser dose than male
![Page 15: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/15.jpg)
Pregnancy• Causes several physiological changes that influence drug
disposition.
• Volume of drug distribution is increased(total body water may increase by up to 8 liters) providing large space for water soluble drugs.
Maternal plasma albumin concentration is reduced,more free drugs will be available
• Metabolic rate is increased, so the free drugs will be available for elimination.
• Cardiac out put is increased, leading to increased renal
blood flow and glomerular filtration and increased renal elimination of drugs.
• Lipophilic molecules readily traverse placental barrier. Drugs that are transferred to fetus are slowly eliminated.
![Page 16: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/16.jpg)
iii) Pregnancy• Avoid drugs during pregnancy due to teratogenic
effectsReasons• Lipophilic drugs cross placental barrier • CO • GFR & renal elimination • Vd• Metabolism of some drugs
E.g., pregnant uterus becomes more sensitive to oxytocin
![Page 17: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/17.jpg)
Pregnancy Safety Index (US FDA)Category A: - controlled studies in women (+) - fail to demonstrate a risk to the fetus in 1st semester and
laterCategory B: - animal- reproduction studies : * no foetal risk, but no controlled studies in
pregnant women * shown an adverse effect, but not confirmed
in controlled studies in women in 1st semester or laterCategory C:
- studies in animal revealed adverse effect (teratogenic or embryogenic or other)
- no controlled studies in women Drugs should be given only if the potential
benefit justifies the potential risk to the fetus
![Page 18: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/18.jpg)
Pregnancy Safety Index (US FDA)
Category D: - there is positive evidence of human foetal risk, but the benefits
for the pregnant women may be acceptable (if the drug is needed in a life –threatening situation)
Category X: - studies in animal and human being foetal
abnormalities - evidence of foetal risk based on human experience - the risk of the use of the drugs in pregnant women
outweights any possible benefit The drug is contraindicated in women who are or
may become pregnant
![Page 19: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/19.jpg)
iv) Lactation
Avoid drugs during lactation due to harm to baby
Drugs easily appear in milk but < therapeutic dose
E.g., tetracycline, sedatives, hypnotics, opoids
![Page 20: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/20.jpg)
V) Body wt./surface area & size
• Conc. Of drug at site of action=ratio b/w body wt. & amount of drug
• D/f quantity of drug for light & heavier persons
• D/f quantity of drug for smaller & larger persons
• Low amount of drug for smaller perosns
![Page 21: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/21.jpg)
vi) food
• Some drugs have interaction with food and they alter the response of drug
• E.g., toxic symptoms appear after eating of cheese, red wine & chicken liver if patient is taking MAOI (more release of NA=fatal cerebral hemorrhage)
![Page 22: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/22.jpg)
Food Presence of fatty food in stomach delays gastric
emptying,the plasma concentration of rifampicin and ampicillin may be much reduced if taken on full stomach
Calcium in milk interferes with absorption of tetracyclines and iron.
Substituting protein for fats and carbohydrates in diet ,increases drug oxidation rates.
![Page 23: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/23.jpg)
Charcoal grilled beef, cabbage, alcohol increases metabolism
Protein malnutrition affects pharmacokinetics of several drugs.
Citrus flavinoids in grape fruit (but not in orange juice) significantly increases absorption of cyclosporin calcium antagonists and probably other drugs
![Page 24: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/24.jpg)
Metabolism – Interaction with food
• Cytochrome P-450 in GI, liver Grapefruit juice made from frozen concentrate will alter this enzyme
• Many drugs for AIDS, HTN
• Effects occur 24 hours after ingestion
![Page 25: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/25.jpg)
Grapefruit Inhibits Metabolism of Many Drugs
• Inactivates metabolizing intestinal enzyme resulting in enhanced activity and possible toxicity
• Effect persists for 72 hours so it is not helpful to separate the drug and the grapefruit
• Many hospitals and health care centers have taken grapefruit products off the menu entirely
![Page 26: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/26.jpg)
• Pathological condition modify drug action
E.g., impaired renal function = drug excretion = drug accumulation
Liver disease= metabolism of drug=accumulation
Cont.
II. Pathological state
![Page 27: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/27.jpg)
PATHOLOGICAL FACTORS
• DISEASES can cause individual variations in drug response.
• Pharmacokinetic variations; Absorption: • Gastric and intestinal stasis during an attack of
Migraine interferes absorption of drugs
• Resection of gut may lead to malabsorption of iron,folic acid and fat soluble vitamins and of vit B12 after ileal resection
![Page 28: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/28.jpg)
• Diarrhea increases the motility of the gut and decreases absorption.
• Hypoalbuminaemia from any cause such as nephrotic syndrome, burn,malnutrition,sepsis allows higher proportion of albumin free drug in plasma which is readily available for metabolism and elimination but there can be risk with initial dose for drugs which are to be highly protein bound
•
![Page 29: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/29.jpg)
• Disease can cause pharmacokinetic or pharmacodynamic variation
a) PK variation Variation in absorption
Gastric statis –in migraineMalbsorption ---ileal or pancreatic disease
Cont.
![Page 30: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/30.jpg)
Variation in distribution
• Altered PPB of phenytoin in chronic renal failure (binding of phenytoin to PPB
Variation in metabolismHepatic cirrhosis & portal HTN
Variation in excretionAcute and /or chronic renal failure
![Page 31: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/31.jpg)
Pharmacodynamic alterations
Variation in receptors• In mysthania gravis, nephrogenic diabetes inspidus,
familial hypercholesterolemia
![Page 32: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/32.jpg)
III. Genetic factors
• It affects drug action due to genetic differences among the races & certain persons in same population
• Genetic variation is an important source of PK variability
Examples:a) Genetic polymorphism= fast/slow acetylators
(hydralazine, procainamide, isoniazid)Cont.
![Page 33: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/33.jpg)
• Plasma choline estrase variant (suxamethonium)
• Hydrooxylase polymorphism (extensive or poor metabolism of debrisoquine)
Ethnic differences in drug metabolism = propranolol, hemolytic anemia due to some oxidizing agents (primaquine, sulphonamides)
![Page 34: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/34.jpg)
• Plasma choline estrase variant (suxamethonium)
• Hydrooxylase polymorphism (extensive or poor metabolism of debrisoquine)
Ethnic differences in drug metabolism = propranolol, hemolytic anemia due to some oxidizing agents (primaquine, sulphonamides)
![Page 35: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/35.jpg)
G6PD (glucose-6-phosphate dehydrogenase) enzyme deficiency
• X-chromosome-linked • Can lead to neonatal jaundice, hemolytic anemia or
acute hemolysis• Most common in African, Middle Eastern, and
Southeast Asians• Also called favism• Fava beans or pollen, Vitamin K or Vitamin C can
cause hemolysis
![Page 36: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/36.jpg)
IV. Environmental factors
Microsomal enzyme inducers
e.g., Hydrocarbons in tobacco smoke, charcoal broiled meat induce CYP1A
Smokers metabolize drugs more rapidly than non smokers
![Page 37: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/37.jpg)
Temperature• Addition of mild to moderate hypothermia
decreases the systemic clearance of CY450 metabolizes drugs between 7-22% per degree Celsius below 37c during cooling. The addition of hypothermia decreases the potency and efficacy of certain drugs .
• The therapeutic index of certain drugs is narrowed during hypothermia.
• Therapeutic hypothermia has shown decrease in neurologic damage in patients experiencing cardiac arrest.
![Page 38: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/38.jpg)
Timings
• It has been observed that endogenous body clock (circadian cycle) may affect the response of the drug.e.g. In CHD(coronary heart diseases) short acting calcium channel blockers seem to be less effective than beta blockers in reducing ischemic events during the night and early morning
![Page 39: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/39.jpg)
Psychological Factors
• Psychological factors can influence individual responses to drugs.
• When placebo drugs are given patients receiving them can report therapeutic and adverse effects.
• Another factor can be patient’s willingness to follow prescribed dosage regimens.
![Page 40: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/40.jpg)
Psychological state
• General anesthetics required in dose for nervous & anxious patients
• Higher doses of chlorpromazine needed in schizophrenics
• Placebos (inert dosage form) produce therapeutic benefits in psychomotor angina pectoris & bronchitis in asthma
![Page 41: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/41.jpg)
Interaction with other drugs
• Administration of one drug (A) can alter action of another drug (B) by PK or PD mechanisms
• This is c/d drug-drug interaction• May be desired or beneficial like multidrug
treatment of tuberculosis• Or undesirable or harmful
![Page 42: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/42.jpg)
Gender• Evidences show that men and women may
respond differently to same drugs
• This may be due to body size, and amount of body fats.
• But there are also some less easily explained differences in gender –specific drug response
• Aspirin shows greater benefit in men than women in cardiovascular diseases
![Page 43: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/43.jpg)
• There appears to be difference in the activity of liver enzymes b/w men and women
• Since the activity of enzymes vary that can result in major difference in drug response
• This difference in liver activity may explain why women routinely wakes up from general anesthesia several minutes before a man given an equal dose.
It has been observed that women with red hair and fair skin are particularly responsive to effects of the analgesic Pentazosine than man of same character.
![Page 44: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/44.jpg)
Interaction out side the body
• Drugs are added to reservoir or syringes to make drugs soluble they are prepared in salt forms, mixing these drugs may lead to precipitation (incompatibility)
• Dilution in reservoir may also lead to loss of stability.
• Protamine in zinc may bind with soluble insulin and delay its effects.
![Page 45: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/45.jpg)
PHARMACOKINETIC Factors• Drug act remotely from target site to alter plasma
concentratione.g. enzyme induction /inhibition
interaction may be synergistic or antagonistic.
Drug interaction can occur at
1. out side the body2. At site of absorption3. During drug distribution4. During drug metabolism5. During drug excretion.6. On receptor or body system.
45
![Page 46: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/46.jpg)
PHARMACODYNAMIC INTERACTIONS• Both drugs act at same target site exerting synergism
or antagonism
• Drugs may act at same or different receptors or process.
• eg alcohal + benzpdiazepines (sedation)
• Morphine + Naloxone ( to reverse opoid overdose)
• Rifampicin + INH ( effective anti TB combination.)
![Page 47: Biomedfactors Modify Pharmacology Actions](https://reader034.fdocuments.net/reader034/viewer/2022042723/577ccd041a28ab9e788b47c1/html5/thumbnails/47.jpg)
Thank you for your attention